Literature DB >> 9786505

Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide.

W F Chiou1, J J Lin, C F Chen.   

Abstract

1. We investigated whether andrographolide, a diterpenoid lactone found at Andrographis paniculata, influences the induction of the inducible nitric oxide synthase (iNOS) in RAW264.7 cells activated by bacterial endotoxin (LPS), as well as in the rats with endotoxic shock and in aortic rings treated with LPS. 2. Incubation of RAW264.7 cells with andrographolide (1 to 50 microM) inhibited the LPS (1 microg ml(-1))-induced nitrite accumulation in concentration- and time-dependent manners. Maximum inhibition was observed when andrographolide was added together with LPS and decreased progressively as the interval between andrographolide and LPS was increased to 20 h. 3. Western blot analysis demonstrated that iNOS expression was markedly attenuated in the presence of andrographolide for 6-24 h, suggesting that andrographolide inhibited iNOS protein induction. 4. Thoracic aorta incubation with LPS (300 ng ml(-1)) for 5 h in vitro exhibited a significant decrease in the maximal contractile response to phenylephrine (10(-9)-10(-5) M). Andrographolide (30 microM) restored the contractile response to control level. 5. In anaesthetized rats, LPS (10 mg kg(-1), i.v.) caused a fall in mean arterial blood pressure (MAP) from 116+/-4 to 77+/-5mmHg. The pressor effect of phenylephrine (10 microg ml(-1), i.v.) was also significantly reduced at 30, 60, 120 and 180 min after LPS injection. In contrast, animals pretreated with andrographolide (1 mg kg(-1), i.v., 20 min prior to LPS) maintained a significantly higher MAP when compared to LPS-rats given with vehicle. Administration of andrographolide 60 min after LPS caused a increase in MAP and significantly reversed the reduction of the pressor response to phenylephrine. 6. Our results indicated that andrographolide inhibits nitrite synthesis by suppressing expression of iNOS protein in vitro. And, this inhibition of iNOS synthesis may contribute to the beneficial haemodynamic effects of andrographolide in endotoxic shock.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786505      PMCID: PMC1565624          DOI: 10.1038/sj.bjp.0702073

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G(1) arrest and apoptosis.

Authors:  S R Jada; C Matthews; M S Saad; A S Hamzah; N H Lajis; M F G Stevens; J Stanslas
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

2.  Neuroprotection of Andrographolide Against Microglia-Mediated Inflammatory Injury and Oxidative Damage in PC12 Neurons.

Authors:  Yuanzhen Xu; Dan Tang; Jianping Wang; Hongbo Wei; Jinming Gao
Journal:  Neurochem Res       Date:  2019-09-27       Impact factor: 3.996

3.  Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide.

Authors:  W F Chiou; C F Chen; J J Lin
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect.

Authors:  Yuh-Chiang Shen; Chieh-Fu Chen; Wen-Fei Chiou
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells.

Authors:  María A Hidalgo; Alex Romero; Jaime Figueroa; Patricia Cortés; Ilona I Concha; Juan L Hancke; Rafael A Burgos
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

Review 6.  Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines.

Authors:  Matthew J Sharman; Giuseppe Verdile; Shanmugam Kirubakaran; Cristina Parenti; Ahilya Singh; Georgina Watt; Tim Karl; Dennis Chang; Chun Guang Li; Gerald Münch
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

7.  Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian).

Authors:  Wen-Wan Chao; Bi-Fong Lin
Journal:  Chin Med       Date:  2010-05-13       Impact factor: 5.455

8.  Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.

Authors:  R A Burgos; J L Hancke; J C Bertoglio; V Aguirre; S Arriagada; M Calvo; D D Cáceres
Journal:  Clin Rheumatol       Date:  2009-04-29       Impact factor: 2.980

9.  Inhibitory effects of neoandrographolide on nitric oxide and prostaglandin E2 production in LPS-stimulated murine macrophage.

Authors:  Jun Liu; Zheng-Tao Wang; Li-Li Ji; Bao-Xue Ge
Journal:  Mol Cell Biochem       Date:  2006-11-16       Impact factor: 3.842

10.  Andrographolide: a new plant-derived antineoplastic entity on horizon.

Authors:  Astha Varma; Harish Padh; Neeta Shrivastava
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.